Oh yes. Via pharmalot and Science Insider:

RePORTER tells us that the NIMH has funded:
1R01MH094759-01A1 “1 OF 2 – PROSPECTIVE DETERMINATION OF PSYCHOBIOLOGICAL RISK FACTORS FOR PTSD”
from 17 May 2012 to April of 2017. With Charles Nemeroff as the Principal Investigator.
To the tune of $401,675 total costs for FY 2012. His institution seems to come in at 53% overhead which would make it $263K in direct. Hmm. Maybe that IDC rate is outdated because why would you bother with a traditional budget just to request another $13K?

if you are wondering, as I was, “2 of 2” appears to be this project. This junior partner in the deal gets only $290K in total costs.

YHN on:
Nemeroff’s third strike
Inselgate
Inselgate linkage

Nothing to say, really. It was a COI case where nobody really laid gloves on the guy for fraud. All he’s really guilty of is underreporting his earnings from Big (and small) Pharma interests to his prior employer Emory U. That should have triggered a stink with his NIH awards but again the rules are about managing conflict…nothing to prove that he actually defrauded the NIH with faked research to benefit his corporate paymasters. Nothing like that ever confirmed. Plus a failure to disclose his conflicts on some review articles or whatnot. Again, if he had disclosed properly it is very likely nothing would have been done differently.

Still, the whole thing smells and I’m sad that it happened in fields which vaguely intersect with my interests. I’m sadder still that the NIH fails to recognize the effect it has on all the scientists who are busting their behinds to secure a grant and do good work that isn’t tainted by conflict and extra-job income to the tune of hundreds of K per year in “consulting” gigs.

Dude. Fuck. Sigh.

UPDATE 052912: Grassley Investigates. Of course. Great move NIMH, great move.